BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System

BD (NYSE:BDX) introduced the Elyra™ Thulium Fiber Laser (TFL) System, an advanced platform for kidney stone and soft tissue procedures.

Rhea-AI Summary

BD (NYSE:BDX) introduced the Elyra™ Thulium Fiber Laser (TFL) System, an advanced platform for kidney stone and soft tissue procedures. The system is designed to enhance efficiency, versatility, and procedural workflow for urology teams.

The air‑cooled Elyra™ and Elyra™ Plus offer efficient stone dusting, reduced stone migration, intuitive interface, quick startup, customizable presets, and an optional wireless footswitch (Plus only). Elyra™ integrates into BD’s end‑to‑end urologic stone management portfolio and is now available in the United States.

Positive

• Launch of Elyra™ and Elyra™ Plus TFL Systems expands BD’s urologic stone portfolio
• System designed for efficient stone dusting and reduced stone migration in procedures
• Air‑cooled design provides quieter operation and smaller footprint than traditional lasers
• Intuitive interface, quick startup, and presets aim to streamline clinical workflows
• Optional wireless footswitch available on Elyra™ Plus enhances procedural flexibility
• First Elyra™ Plus clinical cases completed with positive user feedback on usability and safety features

Negative

• None.

Argus May 21 session

-0.48% close to close Open Argus

Details

News Market Reaction – BDX

On May 21, the day this news came out, BDX closed 0.48% below the previous close.

Data tracked by StockTitan Argus for the May 21 session.

Market Context

This announcement introduces BD’s Elyra Thulium Fiber Laser system, expanding its kidney stone care ...

Analysis

This announcement introduces BD’s Elyra Thulium Fiber Laser system, expanding its kidney stone care portfolio with two configurations aimed at enhancing efficiency and workflow in stone lithotripsy and soft tissue procedures. In recent months, BD also reported Q2 revenue of $4.714 billion, raised adjusted EPS guidance, executed a large share repurchase, and advanced leadership changes. Investors may watch for adoption rates of Elyra, contribution to the broader urology franchise, and how these initiatives influence future earnings updates.

Key Figures

System configurations: 2 configurations Wireless footswitch note: 1 model

System configurations

2 configurations

Elyra and Elyra Plus TFL systems

Wireless footswitch note

1 model

Wireless footswitch only with Elyra Plus

Historical Context

5 past events · Latest: May 18

5 events

1. May 18

   Leadership appointment

   24h Move

   -0.8%

   Named new EVP and president for BD Interventional to support growth.

2. May 07

   CFO appointment

   24h Move

   +5.9%

   Confirmed long-time BD executive as CFO, emphasizing continuity and discipline.

3. May 07

   Earnings update

   24h Move

   +5.9%

   Reported revenue growth, ASR, debt reduction and raised adjusted EPS guidance.

4. May 05

   AI partnership

   24h Move

   -1.5%

   Announced AI-enabled medication management partnership with Wellstar Health System.

5. Apr 30

   Workplace recognition

   24h Move

   +2.6%

   Received multiple awards for employee health and well-being programs.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

thulium fiber laser, stone lithotripsy, urologic stone management

3 terms

thulium fiber laser medical

"The Elyra™ TFL System leverages Thulium Fiber Laser technology to support efficient..."

A thulium fiber laser is a medical-grade laser that generates a concentrated beam from an optical fiber doped with the element thulium, used to cut, vaporize or ablate tissue with high precision and limited heat spread. Investors watch this technology because it can improve clinical outcomes, shrink device size and energy needs, and drive sales and recurring consumables as hospitals replace older systems, making adoption and regulatory approvals key value drivers.

stone lithotripsy medical

"...to help streamline workflows in stone lithotripsy and soft tissue procedures."

Stone lithotripsy is a medical procedure that breaks up solid mineral deposits in the urinary tract (most often kidney stones) into smaller pieces so they can pass naturally or be removed more easily, typically using focused shock waves or laser energy. Investors monitor it because procedure volumes, device and consumable sales, reimbursement rates and clinical effectiveness directly affect hospitals’ and medical-equipment makers’ revenue—similar to how a new popular gadget drives accessory sales.

urologic stone management medical

"...across urologic stone management and soft tissue procedures..."

Urologic stone management describes the range of ways doctors prevent, relieve, or remove mineral stones that form in the kidney or urinary tract, using medicines, non‑invasive sound‑wave treatments, small scope‑based procedures, or temporary drainage tubes. For investors, it matters because demand for these products and services is steady and recurring, driven by rising incidence, procedural innovation, and reimbursement rules—similar to investing in plumbing tools and services for a city with aging pipes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New laser system is designed to help urology teams enhance efficiency, versatility, and procedural workflow across stone management and soft tissue procedures.

FRANKLIN LAKES, N.J., May 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the Elyra™ Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete BD's kidney stone care portfolio for urology teams. Designed to enhance efficiency, versatility, and procedural workflow across urologic stone management and soft tissue procedures, the innovative new system supports consistent performance in demanding clinical environments.

The Elyra™ TFL System leverages Thulium Fiber Laser technology to support efficient stone dusting and reduced stone migration, while its air-cooled design offers quieter operation and a smaller footprint compared to traditional laser systems. The platform is available in two configurations—Elyra™ and Elyra™ Plus—offering flexibility to select the system that best aligns with varying operational needs. Designed with procedural efficiency in mind, the Elyra™ TFL System features an intuitive user interface, quick startup, customizable presets, and an optional wireless footswitch¹ to help streamline workflows in stone lithotripsy and soft tissue procedures.

"Elyra™ demonstrates how BD innovates with speed and purpose, introducing technology that helps clinicians deliver high‑quality care more efficiently," said Mike Cusack, worldwide president of Urology and Critical Care at BD. "By pairing advanced TFL technology with a clinician‑focused design, Elyra™ streamlines kidney stone care and supports greater adaptability across diverse procedural needs."

Developed by BD, the platform enables agility in advancing future generations of the technology, allowing the company to respond quickly to evolving clinician and patient needs.  BD recently completed its first clinical cases using the Elyra™ Plus TFL System at a leading medical center where the system received positive feedback from urologists and laser technicians who engaged with the laser. Users noted the intuitive interface and integrated safety features, which supported ease of use and confidence during procedures.

With Elyra™, BD continues to expand its urologic stone management portfolio, integrating with solutions spanning access, dilation, visualization, fragmentation, removal and drainage, supporting providers with an end-to-end approach across every step. Elyra ™ helps practices optimize performance today while preparing for the future of urologic care.

The Elyra™ and Elyra™ Plus TFL Systems are now available in the United States. For more information, visit the Elyra™ TFL System site.

1	Wireless footswitch only available with Elyra™ Plus

About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at  www.linkedin.com/company/bd1/, X  @BDandCo or Instagram @becton_dickinson.

Contacts:
Media	Investors
Matt Marcus VP, Public Relations Matt.Marcus@bd.com	Shawn Bevec SVP, Investor Relations Investor_Relations@bd.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-delivers-kidney-stone-care-for-urology-teams-with-the-elyra-thulium-fiber-laser-system-302778493.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the Elyra Thulium Fiber Laser System launched by BD (NYSE:BDX)?

The Elyra™ Thulium Fiber Laser (TFL) System is BD’s advanced laser platform for kidney stone and soft tissue procedures. According to BD, it is designed to enhance efficiency, versatility, and workflow for urology teams while supporting consistent performance in demanding clinical environments.

How does BD’s Elyra TFL System improve kidney stone procedures for urology teams?

BD’s Elyra™ TFL System supports efficient stone dusting and reduced stone migration during urologic stone procedures. According to BD, its intuitive interface, quick startup, customizable presets, and optional wireless footswitch are designed to streamline workflows and improve ease of use in clinical settings.

What is the difference between the Elyra and Elyra Plus systems from BD (BDX)?

The Elyra™ platform is offered in two configurations: Elyra™ and Elyra™ Plus, providing operational flexibility. According to BD, Elyra™ Plus uniquely offers an optional wireless footswitch, while both systems share the Thulium Fiber Laser technology and workflow‑focused design features for urology teams.

When will the BD (NYSE:BDX) Elyra TFL System be available in the United States?

The Elyra™ and Elyra™ Plus Thulium Fiber Laser Systems are now available in the United States. According to BD, these systems expand its urologic stone management portfolio and support an end‑to‑end approach across access, dilation, visualization, fragmentation, removal, and drainage.

What clinical feedback has BD received from initial Elyra Plus Thulium Fiber Laser cases?

BD reports that first clinical cases using the Elyra™ Plus TFL System received positive feedback from urologists and laser technicians. According to BD, users highlighted the intuitive user interface and integrated safety features, which supported ease of use and confidence during procedures.

How does Elyra support BD (BDX) in providing end-to-end kidney stone care solutions?

Elyra™ extends BD’s kidney stone care portfolio by integrating with existing stone management solutions. According to BD, the system complements products for access, dilation, visualization, fragmentation, removal, and drainage, helping practices optimize performance today while preparing for future urologic care needs.